Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, designs, info-tech and confidentiality issues from a mainly UK and European perspective. Read, post comments and participate!

The team is Eleonora Rosati, Annsley Merelle Ward and Merpel. E-mail the Kats here!

The team is joined by GuestKats Söğüt Atilla, Oliver Fairhurst, Claire Gregg, Georgia Jenkins and Marcel Pemsel.

SpecialKats: Verónica Rodríguez Arguijo (TechieKat), Rose Hughes (PatKat) and Jocelyn Bosse (Book Review Editor).

InternKats: Wissam Bentazar, Simone Lorenzi and Kliment Markov.
Results for invention
[Guest Post] CJEU weighs in on supplementary protection certificates in Merck v Teva/Clonmel decision [Guest Post] CJEU weighs in on supplementary protection certificates in Merck v Teva/Clonmel decision Reviewed by Jocelyn Bosse on Thursday, February 13, 2025 Rating: 5
[Opinion] Can an AI system be an inventor ? [Opinion] Can an AI system be an inventor ? Reviewed by Annsley Merelle Ward on Monday, December 13, 2021 Rating: 5
AIPPI UK Event Report: AI Generated Innovation AIPPI UK Event Report: AI Generated Innovation Reviewed by Annsley Merelle Ward on Saturday, March 30, 2019 Rating: 5
Once upon a time: Inventive step argumentation as storytelling Once upon a time: Inventive step argumentation as storytelling Reviewed by Annsley Merelle Ward on Monday, April 24, 2017 Rating: 5
Public health and IP in India: Novartis loses Gleevec patent appeal at the Supreme Court Public health and IP in India: Novartis loses Gleevec patent appeal at the Supreme Court Reviewed by Stefano Barazza on Wednesday, April 03, 2013 Rating: 5
Subscribe to: Posts ( Atom )
Powered by Blogger.